Therapies for Children With Autism Spectrum Disorders

2980. Sasso GM, Reimers TM, Cooper LJ, et al. Use of descriptive and experimental analyses to
identify the functional properties of aberrant behavior in school settings. J Appl Behav
Anal. 1992 Winter;25(4):809-21. X-3, X-4, X-10
2981. Saunders RR, Saunders MD, Brewer A, et al. Reduction of self injury in two adolescents
with profound retardation by the establishment of a supported routine. Behavioral
Interventions. 1996 Apr;11(2):59-86. X-10
2982. Sautter RA, LeBlanc LA and Gillett JN. Using Free Operant Preference Assessments to
Select Toys for Free Play between Children with Autism and Siblings. Research in
Autism Spectrum Disorders. 2008 Jan-Mar;2(1):17-27. X-3, X-4
2983. Saw CL, Olivo M, Wohland T, et al. Effects of N-methyl pyrrolidone on the uptake of
hypericin in human bladder carcinoma and co-staining with DAPI investigated by
confocal microscopy. Technol Cancer Res Treat. 2007 Oct;6(5):383-94. X-1, X-4
2984. Sawada M, Negoro H, Iida J, et al. Pervasive developmental disorder with attention deficit
hyperactivity disorder-like symptoms and mismatch negativity. Psychiatry Clin Neurosci.
2008 Aug;62(4):479-81. X-4
2985. Sawyer LM, Luiselli JK, Ricciardi JN, et al. Teaching A Child with Autism to Share
Among Peers in an Integrated Preschool Classroom: Acquisition, Maintenance, and
Social Validation. Education and Treatment of Children. 2005 Feb;28(1):1-10. X-3
2986. Saxena S and Chawla PL. Childhood psychoses: a brief review. Indian J Pediatr. 1984
Mar-Apr;51(409):217-23. X-10
2987. Scahill L. How do I decide whether or not to use medication for my child with autism?
Should I try behavior therapy first? J Autism Dev Disord. 2008 Jul;38(6):1197-8. X-1, X-
2, X-3, X-4
2988. Scahill L, Aman MG, McDougle CJ, et al. Trial design challenges when combining
medication and parent training in children with pervasive developmental disorders. J
Autism Dev Disord. 2009 May;39(5):720-9. X-1, X-3, X-4
2989. Scahill L, Aman MG, McDougle CJ, et al. A prospective open trial of guanfacine in
children with pervasive developmental disorders. J Child Adolesc Psychopharmacol.
2006 Oct;16(5):589-98. X-3
2990. Scahill L, Jekel JF and Schilling LS. Screening child psychiatric inpatients for
communication disorders: a pilot study. Arch Psychiatr Nurs. 1991 Feb;5(1):31-7. X-1,
X-10
2991. Scahill L, Koenig K, Carroll DH, et al. Risperidone approved for the treatment of serious
behavioral problems in children with autism. J Child Adolesc Psychiatr Nurs. 2007
Aug;20(3):188-90. X-1, X-2, X-3
2992. Scahill L, McCracken J, McDougle CJ, et al. Methodological issues in designing a
multisite trial of risperidone in children and adolescents with autism. J Child Adolesc
Psychopharmacol. 2001 Winter;11(4):377-88. X-1, X-3, X-4
2993. Scahill L, McDougle CJ, Williams SK, et al. Children’s Yale-Brown Obsessive
Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child
Adolesc Psychiatry. 2006 Sep;45(9):1114-23. X-4
D-208